Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Kayseri
Clinical trial register · Turkey

Clinical Trials in Kayseri, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
TC Erciyes University34 AstraZeneca19 Novartis Pharmaceuticals12 Kayseri City Hospital11 Merck Sharp & Dohme LLC9
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in Kayseri

183 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Istanbul, Kayseri, Adana, Adapazarı/Turkiye, Afyonkarahisar, Ankara, Çanakkale/Türkiye, Eskişehir
2026-10-26
Not yet open
Çiğdem Ünal Kantekin
Observational
35
Kayseri
2026-10-15
Not yet open
Çiğdem Ünal Kantekin
Not applicable
108
Kayseri
2026-10-15
Not yet open
Kayseri City Hospital
Observational
80
Kayseri
2026-10-15
Not yet open
Effect of Loss-of-Resistance Syringe Training on Endotracheal Tube Cuff Pressure
NCT07844486Endotracheal Tube Cuff Pressure, Postoperative Sore Throat
Yusuf YILMAZ
Observational
180
Kayseri
2026-10-01
Recruiting
The Effect of Using a Stress Ball on Pain, Anxiety, and Vital Signs During Breast Biopsy
NCT07844395Breast Biopsy, Procedural Pain, Anxiety, Vital Signs
TC Erciyes University
Not applicable
53
Kayseri
2026-09-11
Recruiting
Video-Based Grading of Intraoperative Adverse Events in Pediatric Laparoscopic Appendectomy
NCT07794618Appendicitis, Acute, Appendectomy, Intraoperative Complications, Patient Safety
Ahmet Burak Doğan, MD
Observational
80
Kayseri
2026-09-01
Not yet open
Biomarker Panel for PCOS-Associated Liver Steatosis in Adolescent Girls (COMPASS-pedPCOS)
NCT07731373Polycystic Ovary Syndrome (PCOS), Metabolic Dysfunction-Associated Steatotic Liver Disease, Pediatric Obesity, Hyperandrogenism
Kayseri City Hospital
Observational
150
Kayseri
2026-09-01
Recruiting
AstraZeneca
Phase 3
2,800
Adapazarı, Ankara, Antalya, Dinar, İzmit, Kahramanmaraş, Kayseri, Kazımkarabekir
2026-09-01
Recruiting
TC Erciyes University
Not applicable
70
Kayseri
2026-09-01
Recruiting
Novo Nordisk A/S
Phase 3
1,778
Kayseri, Adana, Adana /yüreği̇r, Adapazarı/Turkiye, Afyonkarahisar, Ankara, Gaziantep, Istanbul
2026-08-24
Not yet open
TC Erciyes University
Not applicable
28
Kayseri
2026-08-15
Recruiting
Kayseri City Hospital
Not applicable
60
Kayseri
2026-08-11
Recruiting
Triage Performance and Physiological Predictors of Serious Illness in Febrile Children in the Pediatric Emergency Department
NCT07739004Fever, Triage, Pediatric Emergency Medicine, Serious Bacterial Infection
TC Erciyes University
Observational
3,000
Kayseri, Adana, Antalya, Eskişehir, Istanbul, Izmir, Manisa, Tokat Province
2026-07-28
By invitation
Demet Mutlu
Not applicable
90
Kayseri
2026-07-16
Recruiting
AstraZeneca
Phase 3
800
Adana, Ankara, Bursa, Izmir, Kayseri, Samsun
2026-07-06
Recruiting
AstraZeneca
Phase 3
900
Adana, Ankara, Antalya, Bakırköy, Gaziantep, Kayseri, Yüreğir
2026-07-06
Not yet open
Non-Invasive Diagnostic Panel for MASLD in Children With Obesity
NCT07731360Metabolic Dysfunction-Associated Steatotic Liver Disease, Pediatric Obesity, Insulin Resistance Syndrome
Kayseri City Hospital
Observational
180
Kayseri
2026-07-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
310
Çankaya, Kartal, Adana, Ankara, Kayseri, Mersin, Rize
2026-06-18
Recruiting
Feasibility and Safety of a Pediatric ERAS Protocol for Laparoscopic Appendectomy
NCT07643285Appendectomy, Laparoscopic, Acute Appendicitis, Pediatric Surgery, ERAS
Ahmet Burak Doğan, MD
Not applicable
100
Kayseri
2026-06-15
Recruiting
Biceps Femoris Short Head (BiFeS) Block and Adductor Canal Block for Postoperative Analgesia Following Total Knee Arthroplasty
NCT07577869Postoperative Pain Following Knee Arthroplasty, Total Knee Arthroplasty
Ömer Kayar
Not applicable
60
Kayseri
2026-06-02
By invitation
Effects of High-Velocity Passive Stretch on Spasticity, Function, and Muscle Structure in Spastic CP Children
NCT07007858Cerebral Palsy (CP), Spastic Diplegia Cerebral Palsy, Spastic Hemiplegic Cerebral Palsy
TC Erciyes University
Not applicable
34
Kayseri
2026-06-01
Recruiting
TC Erciyes University
Observational
60
Kayseri
2026-06-01
Not yet open
Pre-emptive Local Anesthesia and Emergence Behavior After Pediatric Dental General Anesthesia
NCT07604337Emergence Delirium, Pediatric Dental General Anesthesia, Postoperative Recovery
seher orbay yasli
Not applicable
80
Kayseri
2026-06
Not yet open
TC Erciyes University
Not applicable
60
Kayseri
2026-06
Not yet open
Kayseri Education and Research Hospital
Observational
200
Kayseri
2026-05-10
Recruiting
AstraZeneca
Observational
2,150
Ankara, Adana, Gaziantep, Istanbul, Kayseri
2026-05-06
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
Adana, Ankara, Istanbul, Izmir, Kayseri
2026-05-04
Recruiting
Kayseri City Hospital
Not applicable
74
Kayseri
2026-05-01
Not yet open
TC Erciyes University
Observational
250
Kayseri
2026-05-01
Not yet open
Kirsehir Ahi Evran Universitesi
Not applicable
100
Kayseri
2026-04-18
Recruiting
TC Erciyes University
Observational
60
Kayseri
2026-04-15
Recruiting
qCON/qNOX-Guided Anesthesia in Patients Undergoing Thyroidectomy Surgery
NCT07445659Thyroid Surgeries, Intraoperative Analgesic Use, Anesthesia Depth Monitoring
Kayseri City Hospital
Not applicable
90
Kayseri
2026-04-10
Active, closed
The Effect of Seed Cycling-Based Nutritional Intervention on Premenstrual Symptoms
NCT07575698Seed Cycling, Nutrition Habits, Premenstrual Syndrome-PMS
TC Erciyes University
Observational
48
Kayseri
2026-03-20
Recruiting
Kayseri City Hospital
Observational
75
Kayseri
2026-03-19
Recruiting
Predicting Spinal Hypotension in Cesarean Section
NCT07499947Spinal Anesthesia, Cesarean Section, Hypotension
TC Erciyes University
Observational
321
Kayseri
2026-03-16
Not yet open
Nuh Naci Yazgan University
Not applicable
140
Kayseri
2026-03-15
Recruiting
Conox-Guided Anesthesia in Pediatric Adenotonsillectomy
NCT07577154Adenotonsillar Hypertrophy, Postoperative Pain
Kayseri City Hospital
Not applicable
128
Kayseri
2026-03-01
Active, closed
Nuh Naci Yazgan University
Not applicable
48
Kayseri
2026-02-26
Active, closed
Kayseri City Hospital
Observational
42
Kayseri
2026-02-05
Active, closed
OST and MORES in Male Osteoporosis
NCT07518212Male Osteoporosis
Kayseri City Hospital
Observational
140
Kayseri
2026-02-04
Not yet open
Havva Talay Çalış
Not applicable
42
Kayseri
2026-02-01
Not yet open
The Impact of Age and Sex on Anticipated and Experienced Pain in First-Time Outpatient Flexible Cystoscopy
NCT07375641Urethral Stricture, Bladder (Urothelial, Transitional Cell) Cancer, Benign Prostate Obstruction (BPO)
Kayseri Education and Research Hospital
Observational
150
Kayseri
2026-02-01
Not yet open
TC Erciyes University
Observational
200
Kayseri
2026-02-01
Recruiting
Insmed Incorporated
Phase 3
344
Adana, Ankara, Bursa, Eskişehir, Kayseri, Kocaeli, Trabzon
2026-01-07
Recruiting
TC Erciyes University
Not applicable
60
Kayseri
2026-01-05
Recruiting
TC Erciyes University
Not applicable
20
Kayseri
2026-01-05
Recruiting
The Effect of Cardiac Rehabilitation on Ferroptosis in Patients With Coronary Artery Disease
NCT07722637Coronary Artery Disease (CAD), Cardiac Rehab, Ferroptosis
TC Erciyes University
Not applicable
90
Kayseri
2026-01-01
By invitation
TC Erciyes University
Not applicable
164
Kayseri
2026-01-01
Not yet open
TC Erciyes University
Observational
250
Kayseri
2026-01
Not yet open
TC Erciyes University
Not applicable
66
Kayseri
2025-12-20
Active, closed
AstraZeneca
Phase 2
222
Adana, Adapazarı, Kahramanmaraş, Kayseri, Kocaeli
2025-12-05
Not yet open
The Effect of Vascular Imaging Devices on Success Rates of Peripheral Vascular Access in Pediatric Patients
NCT07315711Peripheral Vascular Access in Pediatric Patients, Peptic Ulcer, Cataract, Crohn's Disease
Sibel Seçkin Pehlivan
Observational
500
Kayseri
2025-12-01
Recruiting
Grand Shuyang Life Sciences (Chengdu) Co., Ltd.
Phase 3
36
Ankara, Malatya, Istanbul, Kayseri, Mersin, Antalya, Adana, Gaziantep
2025-11-24
Not yet open
TC Erciyes University
Observational
100
Kayseri
2025-11-20
Recruiting
Kayseri City Hospital
Not applicable
80
Kayseri
2025-11-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
996
Sıhhiye, Ankara, Eskişehir, Istanbul, Kayseri, Malatya
2025-11-11
By invitation
TC Erciyes University
Not applicable
48
Kayseri
2025-11-01
Recruiting
Smartwatch Accuracy for Measuring Vitals and Anxiety Before Disc Surgery
NCT07322523Disc Herniations, Disc Herniation, Lumbar, Cervical Disc Herniation, Preoperative Anxiety Score
Halil Kalaycı
Observational
60
Kayseri
2025-11-01
Active, closed
TC Erciyes University
Not applicable
50
Kayseri
2025-10-10
Active, closed
Bayburt University
Not applicable
45
Kayseri
2025-10-01
By invitation
Istanbul Rumeli University
Not applicable
114
Kayseri
2025-09-15
Not yet open
Mediterranean Diet and Disease Activity in Axial Spondyloarthritis Receiving Biologic Therapy
NCT07170384Axial Spondyloarthritis (Ankylosing Spondylitis)
Sinem Kübra Beke
Not applicable
110
Kayseri
2025-09-08
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
NCT06960213Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
ADARx Pharmaceuticals, Inc.
Phase 3
90
Ankara, Bornova, Istanbul, Kayseri
2025-08-28
Not yet open
TC Erciyes University
Not applicable
50
Kayseri
2025-08-15
Active, closed
Ayse Guc
Observational
40
Kayseri
2025-08-13
Recruiting
Ankara University
Observational
150
Adana, Ankara, Denizli, Diyarbakır, Istanbul, Izmir, Kayseri, Kocaeli
2025-08-01
Not yet open
Istanbul Arel University
Not applicable
45
Kayseri
2025-07-15
Recruiting
Takeda
Phase 3
347
Malatya, Şahinbey, Fatih, Kayseri, Kahramanmaraş, Konya, Kocaeli
2025-07-15
Active, closed
ahmet başarı
Not applicable
54
Kayseri
2025-07-08
Recruiting
Helsinn Healthcare SA
Phase 2
95
Istanbul, Ankara, Kayseri
2025-07-07
Recruiting
Inspiratory Muscle Training After Vertebroplasty in Osteoporotic Fracture Patients
NCT07024095Osteoporotic Vertebral Compression Fractures, Restrictive Pulmonary Disorders, Inspiratory Muscle Weakness, Postoperative Pulmonary Function
Istinye University
Not applicable
24
Kayseri
2025-07-01
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
2,400
Sıhhiye, Adana, Ankara, Istanbul, Kayseri, Mersin, Samsun
2025-06-30
Recruiting
AstraZeneca
Phase 2
987
Adana, Ankara, Bursa, İzmit, Kayseri, Mersin
2025-06-27
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Afyonkarahisar, Ankara, Çorum, Istanbul, Izmir, Kayseri, Kocaeli, Konya
2025-06-25
Recruiting
TC Erciyes University
Not applicable
60
Kayseri
2025-06-15
Recruiting
AstraZeneca
Phase 3
15,100
Afyonkarahisar, Ankara, Antalya, Çanakkale, Edirne, Istanbul, Izmir, Kayseri
2025-06-04
Active, closed
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT07037277HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic, Hepatitis C Virus Infection, Hepatitis C
DrugsBemnifosbuvir-Ruzasvir·BEM/RZR·Sofosbuvir-Velpatasvir
Atea Pharmaceuticals, Inc.
Phase 3
880
Adana, Ankara, Bursa, Denizli, Diyarbakır, Istanbul, Kayseri, Samsun
2025-06-02
By invitation
Hacettepe University
Not applicable
56
Kayseri
2025-06-01
Recruiting
TC Erciyes University
Not applicable
70
Kayseri
2025-05-15
Recruiting
Biogen
Phase 3
454
İzmit, Ankara, Istanbul, Sanliurfa, Antalya, Kayseri, Konya
2025-05-08
Recruiting
Nuh Naci Yazgan University
Observational
450
Kayseri
2025-05-01
Active, closed
Burcu ayvazoğlu
Observational
30
Kayseri
2025-04-28
Recruiting
AstraZeneca
Phase 2
540
Adana, Ankara, Bursa, Gaziantep, Istanbul, Kayseri, Mersin
2025-03-26
Recruiting
AstraZeneca
Phase 3
990
Adana, Ankara, Istanbul, Kayseri, Kocaeli, Mersin
2025-03-25
Recruiting
AstraZeneca
Phase 3
5,000
Adana, Adapazarı, Altındağ, Ankara, Antalya, Haliliye, Kahramanmaraş, Kayseri
2025-03-03
Not yet open
The Effect of Skin-to-skin Contact Between Mother and Newborn
NCT06827522Galvanic Skin Response, Skin to Skin Contact
TC Erciyes University
Not applicable
100
Kayseri
2025-02-20
Not yet open
Effects of Virtual Reality Glasses and Meditation Music on Anxiety, Pain, Vital Signs, Satisfaction and Pregnancy Outcomes in Embryo Transfer Procedure
NCT06802692Being Diagnosed With Primary Infertility, Having Had an Embryo Transfer for the First Time
Nuh Naci Yazgan University
Not applicable
105
Kayseri
2025-02-15
Recruiting
Inonu University
Observational
33
Kayseri
2025-02-10
Recruiting
Ondokuz Mayıs University
Observational
600
Kayseri, Samsun
2025-01-25
Recruiting
TC Erciyes University
Phase 4
100
Kayseri
2025-01-01
Recruiting
Sanofi
Phase 2
84
İzmit, Kayseri
2024-12-19
By invitation
TC Erciyes University
Not applicable
110
Kayseri
2024-12-05
Recruiting
Novo Nordisk A/S
Phase 2
465
Kayseri, Adana, Ankara, Gaziantep, Istanbul, Izmir, Kocaeli
2024-12-02
Not yet open
ipek turhan
Not applicable
105
Kayseri
2024-12-01
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Adana, Ankara, Diyarbakır, Edirne, Erzurum, Kayseri, Kocaeli, Sakarya
2024-11-22
Active, closed
TC Erciyes University
Observational
90
Kayseri
2024-11-20
Recruiting
TC Erciyes University
Observational
200
Kayseri
2024-11-15
Active, closed
Sanofi
Phase 2
556
Kayseri, Kirikkale, Mersin
2024-11-07
Recruiting
TC Erciyes University
Not applicable
60
Kayseri
2024-11-01
By invitation
Diabetic Foot Education
NCT06655116Diabetes Mellitus, Diabetic Foot Disease
TC Erciyes University
Observational
82
Kayseri
2024-10-26
Active, closed
Amgen
Phase 3
19
Ankara, Istanbul, Kayseri
2024-10-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Sıhhiye, Adapazarı, Tekirdağ, Adana, Ankara, Istanbul, Kayseri, Trabzon
2024-10-21
Recruiting
Sümeyra Başar
Not applicable
60
Kayseri
2024-10-14
Recruiting
TC Erciyes University
Not applicable
120
Kayseri
2024-10-01
By invitation
Sanofi
Phase 2
900
Bursa, Istanbul, İzmit, Kayseri, Kirikkale, Mersin
2024-09-30
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Bornova, Ankara, Eskişehir, Kayseri, Kocaeli
2024-08-05
Recruiting
AstraZeneca
Phase 3
788
Adapazarı, Altındağ-Ankara, Ankara, Çankaya, Istanbul, Kayseri
2024-08-01
Recruiting
Comparison of Nasal Continuous Positive Airway Pressure (CPAP) Mask and Nasal Airway in Molar Tooth Extraction Under Deep Sedation
NCT06436638Deep Sedation, Non-invasive Ventilation Support, Nasal Airway, Nasal CPAP Mask
Gözde Nur Erkan
Observational
60
Kayseri, Kirikkale
2024-07-02
Active, closed
AstraZeneca
Phase 3
339
Cordaleo, Istanbul, Kayseri, Samsun
2024-06-29
Recruiting
OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia
NCT06430957Obstructive Sleep Apnea Risk Management, Postoperative Complications, Dental Caries Under General Anesthesia, Obstructive Sleep Apnea of Adult
Kırıkkale University
Observational
240
Kayseri, Kirikkale
2024-06-28
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Ankara, Istanbul, Eskişehir, Afyonkarahisar, Antalya, Bursa, Edirne, Kayseri
2024-06-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Stanbul, Ankara, Izmir, Kayseri, Mersin, Samsun
2024-06-10
By invitation
TC Erciyes University
Not applicable
90
Kayseri
2024-06-01
Active, closed
Sanofi
Phase 3
1,541
Antalya, Istanbul, Kayseri, Mersin, Samsun
2024-05-08
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Korfez Mahallesi, Adana, Ankara, Istanbul, Kayseri
2024-04-03
Active, closed
TC Erciyes University
Not applicable
30
Kayseri
2024-04-01
Active, closed
Novo Nordisk A/S
Phase 3
673
Eskişehir, Adana, Afyonkarahisar, Ankara, Bursa, Edirne, Istanbul, Kayseri
2024-04-01
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Ankara, Bursa, Istanbul, Kayseri, Kocaeli, Konya
2024-03-29
Recruiting
AstraZeneca
Phase 3
100
Ankara, Istanbul, Kayseri, Umraniye
2024-03-14
Active, closed
Evaluation of Tooth Sensitivity and Whitening Effects of Different Content Teeth Whitening Agents
NCT06855940Healthy Volunteers, Discoloration of Teeth, Bleaching Sensitivity
Betül Tokat
Not applicable
60
Kayseri
2024-02-02
By invitation
Kayseri Training and Research Hospital
Not applicable
30
Kayseri
2024-02-01
Recruiting
Genexine, Inc.
Phase 3
429
Izmir, Kayseri, Kocaeli
2024-01-25
Active, closed
Pfizer
Phase 3
394
Istanbul, Kayseri, Manisa
2024-01-19
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
100
Ankara, Istanbul, İzmit, Kayseri, Manisa
2024-01-16
Active, closed
Sanofi
Phase 3
943
Ankara, Bursa, Eskişehir, Istanbul, Izmir, İzmit, Kayseri, Konya
2023-12-27
Active, closed
Sanofi
Phase 3
1,655
Ankara, Bursa, Eskişehir, Istanbul, Izmir, İzmit, Kayseri, Konya
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Mamak, Yenimahalle, Ankara, Mezitli, Tekirdağ, Istanbul, Izmir, Kayseri
2023-12-12
Active, closed
Novartis Pharmaceuticals
Phase 3
362
Sakarya, Istanbul, Kayseri
2023-12-07
Active, closed
Kayseri Training and Research Hospital
Not applicable
24
Kayseri
2023-11-23
Active, closed
AstraZeneca
Phase 3
1,902
Adapazarı, Ankara, Istanbul, Kayseri, Samsun
2023-11-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Mamak, Yenimahalle, Ankara, Mezitli, Sakarya, Tekirdağ, Istanbul, Kayseri
2023-11-14
Active, closed
BeOne Medicines
Phase 3
652
Ankara, Kayseri, Kocaeli
2023-11-11
Active, closed
AstraZeneca
Phase 3
1,835
Adapazarı, Ankara, Bursa, Dinar, Kahramanmaraş, Kayseri, Kocaeli
2023-11-07
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Ankara, Kayseri, Samsun
2023-10-12
Recruiting
AbbVie
Phase 3
1,500
Ankara, Gaziantep, Istanbul, Kayseri
2023-10-11
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Istanbul, Izmir, Köseköy, Kayseri, Ankara, Mersin
2023-10-02
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
NCT06051409Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
DrugOlverembatinib
Ascentage Pharma Group Inc.
Phase 3
350
Ankara, Antalya, Istanbul, Izmir, Kayseri, Mersin, Samsun, Tekirdağ
2023-08-31
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Bornova, İzmit, Antalya, Kayseri
2023-07-06
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Ankara, Çankaya, Edirne, Istanbul, Izmir, Kayseri, Yenimahalle
2023-06-22
Active, closed
AbbVie
Phase 3
1,328
Ankara, Bayraklı, Bursa, Istanbul, Kayseri, Samsun
2023-06-21
Recruiting
GlaxoSmithKline
Phase 1/2
123
Istanbul, Kayseri
2023-06-14
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Afyonkarahisar, Ankara, Antalya, Istanbul, Izmir, Kayseri, Mersin, Samsun
2023-04-11
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Izmir, Ankara, Istanbul, Denizli, Kayseri, Muğla, Eskişehir, Gaziantep
2023-03-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
377
Ankara, Istanbul, Izmir, Kayseri, Malatya
2023-02-14
Active, closed
Incyte Corporation
Phase 3
82
Ankara, Center, Istanbul, Izmir, Kayseri, Mersin, Yenimahalle
2022-12-23
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Sakarya, Samsun, Izmir, Aydin, Kayseri, Istanbul
2022-12-09
Recruiting
Pfizer
Phase 3
100
Istanbul, Melikgazi, Adana, Ankara, Izmir, Kayseri, Samsun
2022-12-09
Recruiting
Celgene
Phase 3
810
Ankara, Istanbul, Izmir, Kayseri, Samsun
2022-09-20
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Ankara, Istanbul, Izmir, Kayseri
2022-09-08
Active, closed
Sanofi
Phase 2/3
1,856
Antalya, Gaziantep, Istanbul, Kayseri
2022-08-22
Recruiting
Novartis Pharmaceuticals
Phase 2
240
Ankara, Istanbul, Kayseri, Bursa, Mersin
2022-08-10
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Balkiraz, Yenimahalle, Pamukkale, Bornova, Trabzon, Gaziantep, Istanbul, Kayseri
2022-04-01
Active, closed
Pfizer
Phase 3
854
Istanbul, Izmir, Ankara, Aydin, Kayseri, Kocaeli
2022-03-25
Active, closed
AstraZeneca
Phase 3
363
Adapazarı, Ankara, Istanbul, Izmir, Kahramanmaraş, Kayseri, Kocaeli
2022-02-15
Active, closed
Sanofi
Phase 4
1,339
Adana, Ankara, Istanbul, Izmir, Kayseri, Kirikkale, Mersin
2021-12-16
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Samsun, Izmir, Istanbul, Köseköy, Kayseri, Bursa, Konya
2021-12-13
Recruiting
Pfizer
Phase 3
245
Adana, Ankara, Gaziantep, Istanbul, Izmir, Kayseri, Samsun
2021-11-17
Recruiting
Pfizer
Phase 3
893
Istanbul, Izmir, Adana, Ankara, Antalya, Gaziantep, Kayseri, Kocaeli
2021-10-04
Recruiting
Novartis Pharmaceuticals
Phase 3
540
Istanbul, Köseköy, Antalya, Kayseri, Ankara, Mersin
2021-09-20
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
DrugTacabrutideg
BeOne Medicines
Phase 1/2
689
Balçova, Kayseri, Sakarya, Samsun
2021-09-13
Recruiting
Amgen
Phase 3
60
Ankara, Istanbul, Izmir, Kayseri
2021-09-09
Recruiting
Novartis Pharmaceuticals
Phase 3
98
Istanbul, Kayseri, Ankara
2021-07-28
Active, closed
AstraZeneca
Phase 3
315
Adana, Ankara, Cordaleo, Izmir, Kadıkoy/Istanbul, Kayseri
2021-06-30
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
430
Ankara, Antalya, Edirne, Gaziantep, Izmir, Kayseri, Kocaeli, Mersin
2021-04-09
Active, closed
Loxo Oncology, Inc.
Phase 3
238
Mamak, Faith, Kayseri, Ankara, Izmir
2021-03-09
Active, closed
AstraZeneca
Phase 3
1,371
Adana, Ankara, Izmir, Kayseri
2021-01-28
Active, closed
Hoffmann-La Roche
Phase 3
769
Ankara, Center, Çankaya, Istanbul, Kayseri, Kocaeli, Lzmir, Mersin
2020-12-03
Active, closed
Bayer
Phase 4
654
Adana, Ankara, Edirne, Gaziantep, Istanbul, Izmir, Kayseri, Mersin
2020-11-09
Active, closed
Acerta Pharma BV
Phase 3
611
Ankara, Balçova, Edirne, Izmir, Kayseri, Mersin, Samsun, Trabzon
2020-10-08
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Çukurambar, Şişli, Bornova, Kurupelit, Ortahisar, Ankara, Kayseri
2020-09-16
Active, closed
AstraZeneca
Phase 3
1,012
Ankara, Antalya, Eskişehir, Istanbul, Izmir, Kayseri
2020-07-13
Active, closed
Stichting European Myeloma Network
Phase 2
41
Ankara, Balçova, Kayseri, Pendik
2019-10-31
Recruiting
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
NCT03955445C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis
DrugIptacopan
Novartis Pharmaceuticals
Phase 3
225
Köseköy, Kayseri, Ankara
2019-10-03
Recruiting
Amgen
Phase 3
56
Ankara, Elâzığ, Istanbul, Izmir, Kayseri
2019-04-29
Active, closed
Sanofi
Phase 3
475
Adana, Ankara, Istanbul, Izmir, Kayseri, Samsun
2017-12-07
Active, closed
Eli Lilly and Company
Phase 2
234
Kayseri, Adana, Ankara, Istanbul
2016-09-14
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Adana, Ankara, Edirne, Istanbul, Izmir, Kayseri, Kocaeli
2015-11-19
Active, closed
Acerta Pharma BV
Phase 3
533
Ankara, Instabul, Izmir, Kayseri
2015-07-28
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Istanbul, Kayseri, Ankara, Izmir
2015-03-05
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Ankara, Istanbul, Izmir, Kayseri
2013-09-09
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Ankara, Antalya, Istanbul, Izmir, Kayseri
2013-04
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Ankara, Istanbul, Kayseri
2013-03-18
Rows per page Showing 1–183 of 183
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/kayseri

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 183 of those studies with a site in Kayseri.

How many clinical trials are recruiting in Kayseri?

82 of the 183 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 27 have not yet opened recruitment, 63 are active but closed to new participants, and 11 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kayseri), 183 studies
PhaseStudiesRecruitingShare
Phase 3813844.3%
Not applicable481826.2%
Observational351619.1%
Phase 21166%
Phase 4412.2%
Phase 1/2221.1%
Phase 2/3211.1%

Most active sponsors

Lead sponsors with the most studies (Kayseri)
Lead sponsorStudiesRecruiting
TC Erciyes University3415
AstraZeneca1911
Novartis Pharmaceuticals125
Kayseri City Hospital116
Merck Sharp & Dohme LLC96
Sanofi91
Novo Nordisk A/S52
Pfizer53
Amgen43
Nuh Naci Yazgan University41
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.